BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 22230598)

  • 1. Nurr1 haplotypes are associated with femoropopliteal restenosis/re-occlusion after percutaneous transluminal angioplasty.
    Božič-Mijovski M; Bedenčič M; Stegnar M; Salapura V; Ježovnik MK; Kozak M; Blinc A
    Eur J Vasc Endovasc Surg; 2012 Mar; 43(3):337-8. PubMed ID: 22230598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-6 promoter genotype and restenosis after femoropopliteal balloon angioplasty: initial observations.
    Exner M; Schillinger M; Minar E; Mlekusch W; Sabeti S; Endler G; Raith M; Mannhalter C; Wagner O
    Radiology; 2004 Jun; 231(3):839-44. PubMed ID: 15105457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-molecular-weight heparin for prevention of restenosis after femoropopliteal percutaneous transluminal angioplasty: a randomized controlled trial.
    Koppensteiner R; Spring S; Amann-Vesti BR; Meier T; Pfammatter T; Rousson V; Banyai M; van der Loo B
    J Vasc Surg; 2006 Dec; 44(6):1247-53. PubMed ID: 17145426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brachytherapy for prophylaxis of restenosis after long-segment femoropopliteal angioplasty: pilot study.
    Minar E; Pokrajac B; Ahmadi R; Maca T; Seitz W; Stümpflen A; Pötter R; Ehringer H
    Radiology; 1998 Jul; 208(1):173-9. PubMed ID: 9646810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heme oxygenase-1 gene promoter microsatellite polymorphism is associated with restenosis after percutaneous transluminal angioplasty.
    Exner M; Schillinger M; Minar E; Mlekusch W; Schlerka G; Haumer M; Mannhalter C; Wagner O
    J Endovasc Ther; 2001 Oct; 8(5):433-40. PubMed ID: 11718398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percutaneous transluminal angioplasty with or without stenting for femoropopliteal occlusions? A randomized controlled study.
    Zdanowski Z; Albrechtsson U; Lundin A; Jonung T; Ribbe E; Thörne J; Norgren L
    Int Angiol; 1999 Dec; 18(4):251-5. PubMed ID: 10811511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Doppler sonography diagnosis of restenosis after percutaneous transluminal angioplasty: sensitivity and specificity of the pedal-brachial index in relation to changes in absolute arterial blood pressure].
    Radak Dj; Laps KH; Jeger KA; Ilijevski N; Vojić M
    Srp Arh Celok Lek; 1998; 126(3-4):83-91. PubMed ID: 9863361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infrainguinal cutting balloon angioplasty in de novo arterial lesions.
    Canaud L; Alric P; Berthet JP; Marty-Ané C; Mercier G; Branchereau P
    J Vasc Surg; 2008 Nov; 48(5):1182-8. PubMed ID: 18829233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood fluidity and outcome after femoropopliteal percutaneous transluminal angioplasty (PTA): role of plasma viscosity and low platelet count in predicting restenosis.
    van der Loo B; Kovacevic T; Krieger E; Banyai S; Banyai M; Amann-Vesti BR; Jagacic D; Rousson V; Koppensteiner R
    Clin Hemorheol Microcirc; 2005; 32(2):159-68. PubMed ID: 15764824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated lipoprotein(a) and increased incidence of restenosis after femoropopliteal PTA. Rationale for the higher risk of recurrence in females?
    Maca T; Ahmadi R; Derfler K; Hörl WH; Koppensteiner R; Minar E; Schneider B; Stümpflen A; Ehringer H
    Atherosclerosis; 1996 Nov; 127(1):27-34. PubMed ID: 9006801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endovascular brachytherapy for the prevention of restenosis after femoropopliteal angioplasty. Results of the VARA Trial.
    van Tongeren RB; van Sambeek MR; van Overhagen H; Coen VL; Schmitz PI; Gescher FM; Wittens CH; Vernhout RM; van Urk H; Levendag PC; Bruijninckx CM
    J Cardiovasc Surg (Torino); 2005 Aug; 46(4):437-43. PubMed ID: 16160691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Percutaneous transluminal angioplasty and enclosed thrombolysis versus percutaneous transluminal angioplasty in the treatment of femoropopliteal occlusions: results of a prospective randomized trial.
    Nicholson T
    Cardiovasc Intervent Radiol; 1998; 21(6):470-4. PubMed ID: 9853164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The natural history of duplex-detected stenosis after femoropopliteal endovascular therapy suggests questionable clinical utility of routine duplex surveillance.
    Bui TD; Mills JL; Ihnat DM; Gruessner AC; Goshima KR; Hughes JD
    J Vasc Surg; 2012 Feb; 55(2):346-52. PubMed ID: 21975061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of simvastatin on restenosis after percutaneous transluminal angioplasty of femoropopliteal arterial obstruction.
    Hagenaars T; Gussenhoven EJ; van Sambeek MR; Jukema JW; Kranendonk SE; Bom N
    Am J Cardiol; 2000 Oct; 86(7):774-6, A6. PubMed ID: 11018199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Excimer laser with adjunctive balloon angioplasty and heparin-coated self-expanding stent grafts for the treatment of femoropopliteal artery in-stent restenosis: twelve-month results from the SALVAGE study.
    Laird JR; Yeo KK; Rocha-Singh K; Das T; Joye J; Dippel E; Reddy B; Botti C; Jaff MR
    Catheter Cardiovasc Interv; 2012 Nov; 80(5):852-9. PubMed ID: 22422738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of endovascular interventions for TASC II B and C femoropopliteal lesions.
    Baril DT; Marone LK; Kim J; Go MR; Chaer RA; Rhee RY
    J Vasc Surg; 2008 Sep; 48(3):627-33. PubMed ID: 18727966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of smoking on restenosis during the 1st year after lower-limb endovascular interventions.
    Schillinger M; Exner M; Mlekusch W; Haumer M; Sabeti S; Ahmadi R; Wagner O; Minar E
    Radiology; 2004 Jun; 231(3):831-8. PubMed ID: 15163820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. De novo superficial femoropopliteal artery lesions: peripheral cutting balloon angioplasty and restenosis rates--randomized controlled trial.
    Amighi J; Schillinger M; Dick P; Schlager O; Sabeti S; Mlekusch W; Haumer M; Mathies R; Heinzle G; Schuster A; Loewe C; Koppensteiner R; Lammer J; Minar E; Cejna M
    Radiology; 2008 Apr; 247(1):267-72. PubMed ID: 18270378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of hemostatic risk factors for restenosis in peripheral arterial occlusive disease after transluminal angioplasty.
    Tschopl M; Tsakiris DA; Marbet GA; Labs KH; Jäger K
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3208-14. PubMed ID: 9409313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neointimal hyperplasia after silverhawk atherectomy versus percutaneous transluminal angioplasty (PTA) in femoropopliteal stent reobstructions: a controlled, randomized pilot trial.
    Brodmann M; Rief P; Froehlich H; Dorr A; Gary T; Eller P; Hafner F; Deutschmann H; Seinost G; Pilger E
    Cardiovasc Intervent Radiol; 2013 Feb; 36(1):69-74. PubMed ID: 23007223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.